More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

DCAT Value Chain Insights

The European Investment Bank is teaming with the Belgian biopharmaceutical company UCB in a new model for financing research and innovation projects in the European Union. Research and development (R&D) represent the lifeblood of the...
DCAT Value Chain Insights

The pharmaceutical industry has intensified its new product development efforts in biologics, but has it paid off? A look at the most successful biologic-based drugs launched over the past five years. As the industry gathers this week for the...
DCAT Value Chain Insights

How does sustainability fit into overall investment decisions and practices? Is it a way to achieve competitive advantage? A recent PwC analysis says "yes" as it examines the role of sustainability in financial decision-making. What is the...
DCAT Value Chain Insights

The BRIC (Brazil, Russia, India, and China) countries are important engines of growth for the global pharmaceutical industry, but how does manufacturing activity align with that growth? A look into Russia's pharmaceutical market and the...